UnitedHealth Group Incorporated $UNH Stock Acquired by Quintet Private Bank Europe S.A.

Quintet Private Bank Europe S.A. grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 40.9% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 70,325 shares of the healthcare conglomerate’s stock after acquiring an additional 20,419 shares during the period. UnitedHealth Group comprises 1.2% of Quintet Private Bank Europe S.A.’s investment portfolio, making the stock its 21st biggest position. Quintet Private Bank Europe S.A.’s holdings in UnitedHealth Group were worth $25,815,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. Toth Financial Advisory Corp increased its stake in shares of UnitedHealth Group by 14.3% in the third quarter. Toth Financial Advisory Corp now owns 29,917 shares of the healthcare conglomerate’s stock worth $10,982,000 after purchasing an additional 3,753 shares in the last quarter. Whalen Wealth Management Inc. boosted its holdings in UnitedHealth Group by 1.4% in the 3rd quarter. Whalen Wealth Management Inc. now owns 4,755 shares of the healthcare conglomerate’s stock worth $1,745,000 after buying an additional 66 shares during the period. Vann Equity Management LLC bought a new stake in UnitedHealth Group during the 3rd quarter valued at $795,000. HWG Holdings LP boosted its holdings in shares of UnitedHealth Group by 20.7% in the third quarter. HWG Holdings LP now owns 16,839 shares of the healthcare conglomerate’s stock worth $6,181,000 after acquiring an additional 2,892 shares during the period. Finally, Venture Visionary Partners LLC bought a new stake in shares of UnitedHealth Group during the 3rd quarter valued at $3,277,000. 87.86% of the stock is owned by institutional investors.

Insider Activity at UnitedHealth Group

In related news, CEO Patrick Conway sold 1,169 shares of the company’s stock in a transaction on Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the sale, the chief executive officer directly owned 15,328 shares in the company, valued at $5,977,920. This represents a 7.09% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 0.19% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

UNH has been the subject of a number of recent analyst reports. Wells Fargo & Company lifted their target price on UnitedHealth Group from $397.00 to $485.00 and gave the company an “overweight” rating in a report on Monday, July 13th. TD Cowen raised their price objective on shares of UnitedHealth Group from $337.00 to $430.00 and gave the company a “hold” rating in a research report on Tuesday, July 14th. The Goldman Sachs Group increased their target price on shares of UnitedHealth Group from $435.00 to $490.00 and gave the stock a “buy” rating in a research note on Friday, July 17th. HSBC upped their price target on shares of UnitedHealth Group from $300.00 to $380.00 and gave the stock a “hold” rating in a report on Monday, July 6th. Finally, Morgan Stanley boosted their target price on UnitedHealth Group from $468.00 to $529.00 and gave the stock an “overweight” rating in a research report on Friday, July 17th. Twenty analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $465.75.

UnitedHealth Group Trading Down 0.9%

Shares of UnitedHealth Group stock traded down $3.48 during trading on Thursday, reaching $372.50. The company’s stock had a trading volume of 1,676,218 shares, compared to its average volume of 7,328,772. The company has a quick ratio of 0.78, a current ratio of 0.78 and a debt-to-equity ratio of 0.66. The company has a market cap of $334.35 billion, a price-to-earnings ratio of 24.00, a PEG ratio of 1.41 and a beta of 0.60. The firm’s 50-day moving average is $390.52 and its two-hundred day moving average is $379.64. UnitedHealth Group Incorporated has a 52-week low of $255.96 and a 52-week high of $461.62.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.94 by $1.44. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The business had revenue of $112.03 billion during the quarter, compared to analyst estimates of $110.81 billion. During the same period in the prior year, the business posted $4.08 earnings per share. The company’s revenue was up .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 19.85 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th were paid a dividend of $2.32 per share. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date of this dividend was Monday, September 14th. UnitedHealth Group’s dividend payout ratio is 59.72%.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth’s valuation has reset substantially after a difficult period, with its lower price-to-earnings multiple prompting some investors to view the stock as undervalued if earnings stabilize and Medicare Advantage margins recover. UnitedHealth’s P/E Has Reset. Is the Stock Finally Undervalued?
• Positive Sentiment: Analysts and investors are closely watching UnitedHealth ahead of its third-quarter report, suggesting that expectations for a potential earnings improvement remain an important catalyst for the stock. The company’s latest quarter exceeded consensus EPS and revenue estimates. Stay Ahead of the Game With UnitedHealth Q3 Earnings
• Neutral Sentiment: Third-quarter results will be judged on medical-cost trends, Medicare Advantage margins, membership changes and operating performance—not simply revenue and EPS. Investors are looking for evidence that recent margin pressure is temporary and that the company can maintain its full-year outlook. UnitedHealth Q3 Coming Up: Two Questions Investors Can’t Ignore
• Neutral Sentiment: UnitedHealth is attracting unusually high investor attention, but the coverage largely reflects debate over whether the stock’s depressed valuation represents an opportunity or a signal of continued fundamental risk. UnitedHealth Group Is Attracting Investor Attention
• Negative Sentiment: A recent rating downgrade highlights a weak spot in UnitedHealth’s recovery and reinforces concerns that higher medical expenses or slower improvement in Medicare Advantage could limit earnings momentum. UnitedHealth’s Recovery Has One Weak Spot
• Negative Sentiment: Reports about Medicare plan closures and potential member disruption add reputational and enrollment risk, while investors remain concerned that membership losses could make margin improvement harder to achieve. Medicare Plans Are Shutting Down

UnitedHealth Group Profile

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care and well-being company serving individuals, employers, health care providers and government programs. Its operations are organized primarily through UnitedHealthcare and Optum.

UnitedHealthcare provides health benefit plans and services, including employer-sponsored coverage, individual and family plans, Medicare and Medicaid offerings, and other government-supported programs. Its services include health insurance administration, pharmacy benefits and care management.

Optum provides health care services, technology and data solutions, pharmacy services, and analytics to health plans, employers, government agencies, health care providers and consumers.